Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN)

NCT01704716 is registered in ClinicalTrials.gov with St. Anna Kinderkrebsforschung as lead sponsor.

NCT NCT01704716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01704716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN)
Lead sponsor
St. Anna Kinderkrebsforschung
Phase
Phase 3
Overall status
Recruiting
Start date
February 28, 2002
Completion date
September 30, 2026
Enrollment
3,300 (estimated)
Sites
126

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma